Success Story: Thanks To Our Filing, We Helped a Chinese Research Fellow Achieve EB1A Success Smoothly
Client’s Testimonial:
"The lawyer is highly experienced in preparing petitions tailored to my background. They answered all my questions in a timely manner and finished the draft very efficiently."
On January 3rd, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Fellow in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Research Fellow
Country of Origin: China
State of Residence at the Time of Filing: New York
Approval Notice Date: January 3rd, 2025
Processing Time: 3 months, 18 days (Premium Processing Upgrade Requested)
Case Summary:
North America Immigration Law Group (Chen Immigration Law Associates) is pleased to share an I-140 EB-1A (Alien of Extraordinary Ability) approval for the client, a biomedical scientist whose work focuses on biomolecular processes involved in immunological inflammatory responses.
Research Focus With a Ph.D. in physiology, the client has developed a specialized research profile at the intersection of virology, inflammation, and disease mechanisms. Within biomedical science, the client is particularly recognized for work identifying epitopes that distinguish the West Nile Virus, along with research that advances scientific understanding of inflammatory pathways relevant to bone biology and metabolic disease.
The client currently works in a research role at a U.S.-based academic medical environment, where the focus includes studying gene expression and signaling relevant to inflammatory diseases, particularly those affecting the bones. This ongoing work aligns the client’s prior research strengths with continued efforts to refine disease models and inform downstream applications related to prevention and treatment.
An Evidentiary Record In EB-1A cases, strong metrics can support a petition, but adjudicators typically look for evidence that those metrics reflect independent recognition and sustained influence, not just productivity. We presented the client’s record in a way that tied the numbers to a clear narrative of field-wide reliance on the client’s findings and methods.
The petition highlighted the client’s publication and impact record:
- 20 peer-reviewed journal articles
- 249 citations
Peer-Recognized Authority We also emphasized peer-review service as an indicator of recognized expertise. Serving as a reviewer is a responsibility typically reserved for researchers viewed as capable of evaluating scientific rigor and significance in the field. The client’s completion of at least 9 reviews helped show that the client is regarded as a trusted evaluator of others’ work, reinforcing a record of professional authority beyond authorship alone.
In addition, the petition included evidence that the client’s research has been supported by major competitive funding sources in the United States and abroad. Strategically, this funding history was presented as contextual support that the client’s work aligns with high-priority scientific objectives and has earned confidence from selective funding mechanisms.
Expert Recommendation Letters To corroborate the objective evidence, the petition included four letters of recommendation from experts familiar with the client’s work. These letters were used to connect the client’s research contributions to their broader significance, explaining how the client’s findings have influenced ongoing research directions in immunological inflammatory responses and related disease areas.
“In light of these facts, [Client’s] work is indubitably instrumental to current and future biomedical research in America.”
The Result The EB-1A I-140 petition was approved, reflecting that the case presentation effectively framed the client’s achievements as sustained, field-recognized impact in biomedical science, supported by a documented publication record, meaningful independent citations, peer-review activity, evidence of major research support, and expert testimony

